研究兴趣

论文共 139 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
PP01.44 Long-Term Survival and Outcomes by Race from the Phase I/II trial of Carboplatin, Nab-paclitaxel, and Pembrolizumab for Advanced NSCLC: HCRN LUN13-175
R. Gentzler, N. Mohindra, S. Jalal, K. Reckamp, R. Hall, N. Hanna,Y. Chae, M. Koczywas,I. Helenowski,J. Patel
Journal of Thoracic Oncologyno. 3 (2023): e29
引用0浏览0引用
0
0
Clinical characteristics, real-world treatment patterns, and clinical outcomes among patients with previously treated metastatic or unresectable EGFR-mutated non-small cell lung cancer in the United States
Jyoti D. Patel, Jie Meng, Sudarshan Phani, Aaron Crowley, Summera Zhou, Maribel Salas, Yoko Tanaka, Hoa Le, Jeffrey Anderson,Karen L. Reckamp
CANCER RESEARCHno. 7 (2023)
引用0浏览0引用
0
0
Prevalence of incidental pathogenic germline variants detected in cfDNA in patients with oncogene-driven non-small cell lung cancer
Laura Mezquita, Leslie A. Bucheit, Juan Carlos Laguna, Belen Pastor,Cristina Teixido, Teresa Gorria, Victor Albarran-Artahona, Marta Garcia De Herreros, Roxana Reyes,Noemi Reguart, Nuria Vinolas, Ainara Arcocha,
JOURNAL OF CLINICAL ONCOLOGY（2022）
引用0浏览0引用
0
0
TRLS-03. Intracranial activity of tepotinib in patients with MET exon 14 (METex14) skipping NSCLC enrolled in VISION
Christine M. Bestvina, Xiuning Le,Remi Veillon, Ian Churchill Anderson,Jyoti D. Patel, Ingel K. Demedts,M.C. Garassino, Julien Mazieres, Masahiro Morise,Egbert F. Smit, S. Peter Eggleton, Aurora O'Brate,
Neuro-Oncology Advances (2021)
引用0浏览0引用
0
0
Intracranial activity of tepotinib in patients (pts) with MET exon 14 (METex14) skipping NSCLC enrolled in VISION
Jyoti D. Patel,Xiuning Le,Remi Veillon, Ian Churchill Anderson, Christine M. Bestvina, Ingel Demedts, Marina Chiara Garassino, Julien Mazieres, Masahiro Morise,Egbert F. Smit, S. Peter Eggleton, Aurora OBrate,
Journal of Clinical Oncology（2021）
引用0浏览0引用
0
0
加载更多
作者统计
  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn